News
Cervical Cancer Screening: US Clinicians Unclear About Best Practices
- Author:
- Helen Leask, PhD
ACS guidelines mark a notable departure from prevailing practice.
News
Time to stop routine maintenance therapy in myeloma?
- Author:
- Helen Leask, PhD
Research now suggests some multiple myeloma patients may not need indefinite, costly maintenance therapy after stem cell transplantation.
News
Have early-onset cancer cases soared? Not so fast, experts say
- Author:
- Helen Leask, PhD
“Epidemic news, but no epidemic of cancer.”
News
New trials in prostate cancer: Could your patient benefit?
- Author:
- Helen Leask, PhD
Several new trials have opened in recent months.
News
Cancer clinical trials: Can industry stack the deck?
- Author:
- Helen Leask, PhD
Experts: New research into age disparities in cancer drug trials finds participants “markedly younger” than intended patient populations.
News
Mastocytosis: Rare, underdiagnosed, potentially fatal
- Author:
- Helen Leask, PhD
This often-missed myeloid neoplasm could be deadly and deserves greater attention, experts say.
News
Cervical cancer in women 65+ often deadly: so why not screen?
- Author:
- Helen Leask, PhD
Older patients, even those with early disease, had much poorer survival after they were diagnosed with cervical cancer than their younger...
News
Teclistamab for MM: Lifesaver or 'cause of death'?
- Author:
- Helen Leask, PhD
In the wake of the FDA’s accelerated approval of teclistamab, myeloma specialists interpret the pros and cons.
News
Noted oncologist ponders death, life, care inequities
- Author:
- Helen Leask, PhD
A photojournalist-turned-physician practiced in India and the United Kingdom before rising to prominence in U.S. community oncology.
News
When CPI fails, HL patients should get timely allo-HCT
- Author:
- Helen Leask, PhD
New data suggest that physicians should refer Hodgkin lymphoma patients for allogeneic HCT without delay when PD-1 treatments fail.
News
Survivor’s story foreshadows one of oncology’s greatest successes
- Author:
- Helen Leask, PhD
In 1992, a young New Yorker was among the first Hodgkin lymphoma patients to undergo a successful bone marrow transplant. Three decades later,...
News
100 coauthored papers, 10 years: Cancer transplant pioneers model 'team science'
- Author:
- Helen Leask, PhD
MSKCC medical oncologists share expertise in HSCT, Spanish background, a gift for mentoring, and 100 peer-reviewed publications written together...